Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc. (HTGM) Stock Overview

Explore HTG Molecular Diagnostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HTGM●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.48
$0.00(0.00%)
U.S. Market opens in 11h 44m

HTG Molecular Diagnostics, Inc. (HTGM)

Meyka AI Score

Z

Key Financials

Market Cap1.1M
P/E Ratio-2.00
EPS (TTM)$-17.10
ROE-2.73%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

HTGM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, HTG Molecular Diagnostics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HTGM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind HTG Molecular Diagnostics, Inc.'s NASDAQ-traded stock include a P/E ratio of -2.00 and a market capitalization of 1.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HTGM on the NASDAQ.

Price Performance (NASDAQ: HTGM)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-83.89%
6-Month Change
-90.22%
Year-to-Date (YTD) Change
-88.26%
1-Year Change
-97.80%
3-Year Change
-99.51%
5-Year Change
-99.92%
All-Time (Max) Change
-99.98%

Contact Information

https://www.htgmolecular.com
877 289 2615
3430 East Global Loop, Tucson, AZ, 85706

Company Facts

530 Employees
IPO DateMay 6, 2015
CountryUS

Frequently Asked Questions